Abstract
No public abstract is available from the verified source records.
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The 2023 bethesda system for reporting thyroid cytopathology
2023
Thyroid hormone suppression therapy
10.1016/j.ecl.2018.10.008 · 2019
Hormone replacement therapy after total thyroidectomy. Can the combined treatment be considered effective to get metabolic adequacy? Preliminary results
2010
Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma
10.1677/erc.0.0100601 · 2003
Thyroid cancer: A review
10.1001/jama.2023.26348 · 2024
The thyroid hormone axis and female reproduction
10.3390/ijms24129815 · 2023
Hypothyroidism and cognition: Preliminary evidence for a specific defect in memory
10.1089/10507250152741037 · 2001
Is cognitive change related to hypothyroidism reversible with replacement therapy?
10.1016/s0248-8663(00)80022-3 · 2000
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
10.1172/jci46382 · 2011
Unresolved referenced work
Kept as external metadata until matched
Thyroid cancer
10.1016/s0140-6736(23)00020-x · 2023
Hormone replacement therapy with L-thyroxine promotes working memory and concentration in thyroidectomized female patients after differentiated thyroid carcinoma
10.1177/0091217419885751 · 2020
Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism
10.1210/jc.2008-2702 · 2009
Chemotherapy and cognitive impairment: Treatment options
10.1038/clpt.2011.112 · 2011
Benefits of physical activity during and after thyroid cancer treatment on fatigue and quality of life: A systematic review
10.3390/cancers14153657 · 2022
Pre-surgery depression and confidence to manage problems predict recovery trajectories of health and wellbeing in the first two years following colorectal cancer: Results from the CREW cohort study
10.1371/journal.pone.0155434 · 2016
Clinical review: The thyroid in mind: Cognitive function and low thyrotropin in older people
10.1210/jc.2012-2284 · 2012
Association between thyroid dysfunction and incident dementia in the atherosclerosis risk in communities neurocognitive study
10.14740/jem588 · 2019
Differentiated thyroid cancer: A focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy
10.1007/s12020-023-03548-8 · 2024
The effect of thyrotropin suppression on survival outcomes in patients with differentiated thyroid cancer: A systematic review and meta-analysis
10.1089/thy.2023.0711 · 2024
American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer
10.1089/thy.2015.0020 · 2016
Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: A prospective Swedish population-based study
10.1089/thy.2018.0388 · 2018
Evaluating cognitive function in patients with differentiated thyroid cancer who experienced shortterm hypothyroidism by levothyroxine withdrawal using Montreal cognitive assessment-Philippines (MoCA-P) tool
10.54029/2023knd · 2023
Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma
2012
Testosterone: Much more for the brain than a sex hormone
10.1016/j.bja.2022.01.002 · 2022
Predictors of poor prognosis in long-term survivors of differentiated thyroid cancer with psychiatric disorders
10.5498/wjp.v15.i5.103628 · 2025
Naming difficulties after thyroid-stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: A prospective cohort study
10.1007/s12020-019-01943-8 · 2019
Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma
10.1007/s00520-016-3481-y · 2017
Cognitive impairment in women newly diagnosed with thyroid cancer before treatment
10.1007/s00520-022-07299-6 · 2022
Immediate-term cognitive impairment following intravenous (IV) chemotherapy: A prospective pre-post design study
10.1186/s12885-019-5349-2 · 2019
Diagnostic performance of six ultrasound risk stratification systems for thyroid nodules: A systematic review and network meta-analysis
10.2214/ajr.22.28556 · 2023
Thyroid stimulating hormone, cognitive impairment and depression in an older Korean population
10.4306/pi.2010.7.4.264 · 2010
Regulation of thyroid cell proliferation by TSH and other factors: A critical evaluation of in vitro models
10.1210/edrv.22.5.0444 · 2001
Thyroid dysfunction and cancer incidence: A systematic review and meta-analysis
10.1530/erc-19-0417 · 2020
Treated hypothyroidism, cognitive function, and depressed mood in old age: The rancho bernardo study
10.1530/eje-09-0606 · 2009
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: A systematic review of the literature
10.1210/jc.2014-3882 · 2015
Cognitive function and postoperative outcomes in patients with head and neck cancer
10.1002/lary.30677 · 2023
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer
10.1056/nejmoa2111953 · 2022
Neurocognitive impairment as one facet of cancer-related sickness behavior symptoms
10.1093/jnci/djv176 · 2015
Thyroid function, alzheimer's disease and postoperative cognitive dysfunction: A tale of dangerous liaisons
10.3233/jad-2008-14109 · 2008
Impact of menopausal status on cognitive function in female papillary thyroid carcinoma patients: A longitudinal propensity score matched study
10.1186/s12905-024-03503-3 · doi-reference
Cognitive impairment in men with testicular cancer prior to adjuvant therapy
10.1002/cncr.25298 · doi-reference
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
10.1002/cncr.25098 · doi-reference
Affective symptoms and cognitive functions in the acute phase of graves' thyrotoxicosis
10.1016/j.psyneuen.2006.09.012 · doi-reference
Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: A prospective, longitudinal, controlled study
10.1200/jco.2015.63.0905 · doi-reference
Changes in cognitive functions caused by acute hypothyroidism during withdrawal of l-thyroxine in patients with differentiated thyroid carcinoma
10.5152/erp.2024.24442 · doi-reference
A systematic review of the association between psychological stress and dementia risk in humans
10.3233/jad-191096 · doi-reference
Association between anaesthesia-related factors and postoperative neurocognitive disorder: A post-hoc analysis
10.1186/s12871-023-02318-3 · doi-reference
Screening leads to overestimated associations of thyroid dysfunction and thyroiditis with thyroid cancer risk
10.3390/cancers13215385 · doi-reference
Thyroid hormones, brain function and cognition: A brief review
10.1016/s0149-7634(01)00037-9 · doi-reference
The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition
10.1210/jc.2013-3686 · doi-reference
Psychiatric and cognitive manifestations of hypothyroidism
10.1097/med.0000000000000089 · doi-reference
Cognitive functioning in thyroid cancer survivors: A systematic review and meta-analysis
10.1007/s11764-019-00745-1 · doi-reference
The relationship between quality of life, cognition, and thyroid status in graves' disease
10.1007/s12020-018-1733-y · doi-reference
Total thyroidectomy: Reduction in postoperative hypoparathyroidism
10.1530/ec-23-0198 · doi-reference
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
10.1530/eje.1.02158 · doi-reference
Thyroid hormone regulates endogenous amyloid-beta precursor protein gene expression and processing in both in vitro and in vivo models
10.1089/thy.2006.16.1207 · doi-reference
Risk factors and prediction model for cancer-related cognitive impairment in thyroid cancer patients
10.62347/aotu1301 · doi-reference
Interleukin-6 is an early plasma marker of severe postoperative complications in thoracic surgery: Exploratory results from a substudy of a randomized controlled multicenter trial
10.1213/ane.0000000000005639 · doi-reference
The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma
10.1210/jc.2013-4454 · doi-reference
Neuropsychological functioning among patients with different types of cancer: Postchemotherapy cognitive impairment and implications for rehabilitation
10.1007/s40211-020-00345-x · doi-reference
Thyroid function, alzheimer's disease and postoperative cognitive dysfunction: A tale of dangerous liaisons
10.3233/jad-2008-14109 · doi-reference
Neurocognitive impairment as one facet of cancer-related sickness behavior symptoms
10.1093/jnci/djv176 · doi-reference
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer
10.1056/nejmoa2111953 · doi-reference
Cognitive function and postoperative outcomes in patients with head and neck cancer
10.1002/lary.30677 · doi-reference
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: A systematic review of the literature
10.1210/jc.2014-3882 · doi-reference
Treated hypothyroidism, cognitive function, and depressed mood in old age: The rancho bernardo study
10.1530/eje-09-0606 · doi-reference
Thyroid dysfunction and cancer incidence: A systematic review and meta-analysis
10.1530/erc-19-0417 · doi-reference
Regulation of thyroid cell proliferation by TSH and other factors: A critical evaluation of in vitro models
10.1210/edrv.22.5.0444 · doi-reference
Thyroid stimulating hormone, cognitive impairment and depression in an older Korean population
10.4306/pi.2010.7.4.264 · doi-reference
Diagnostic performance of six ultrasound risk stratification systems for thyroid nodules: A systematic review and network meta-analysis
10.2214/ajr.22.28556 · doi-reference
Immediate-term cognitive impairment following intravenous (IV) chemotherapy: A prospective pre-post design study
10.1186/s12885-019-5349-2 · doi-reference
Cognitive impairment in women newly diagnosed with thyroid cancer before treatment
10.1007/s00520-022-07299-6 · doi-reference
Naming difficulties after thyroid-stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: A prospective cohort study
10.1007/s12020-019-01943-8 · doi-reference
Predictors of poor prognosis in long-term survivors of differentiated thyroid cancer with psychiatric disorders
10.5498/wjp.v15.i5.103628 · doi-reference
Testosterone: Much more for the brain than a sex hormone
10.1016/j.bja.2022.01.002 · doi-reference
Evaluating cognitive function in patients with differentiated thyroid cancer who experienced shortterm hypothyroidism by levothyroxine withdrawal using Montreal cognitive assessment-Philippines (MoCA-P) tool
10.54029/2023knd · doi-reference
Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: A prospective Swedish population-based study
10.1089/thy.2018.0388 · doi-reference
American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer
10.1089/thy.2015.0020 · doi-reference
The effect of thyrotropin suppression on survival outcomes in patients with differentiated thyroid cancer: A systematic review and meta-analysis
10.1089/thy.2023.0711 · doi-reference